ra-2

RA-2 is a pan-negative-gating modulator of KCa2/3 channels that acts by inhibiting EDH-type relaxation in coronary arteries.

Ginsenoside Ra2 is a natural product found in ginseng with inhibitory activity against Angiotensin-converting enzyme (IC50= 385.59 µM).

Ginsenoside Ra2 (Standard) is a reference standard for research and analysis in studies involving Ginsenoside Ra2. Ginsenoside Ra2 is a natural product found in ginseng with inhibitory activity against Angiotensin-converting enzyme (IC50= 385.59 µM).

IDRA-21 is a positive AMPA receptor modulator.

TYRA-200 is an orally active FGFR1/2/3 inhibitor that induces dose-dependent tumor regression in wild-type and mutant FGFR2 models, making it a candidate for advanced or metastatic intrahepatic cholangiocarcinoma.

PYRA-2 is a CDC7 kinase inhibitor with potential applications in cancer research.

CRA-2059 hydrochloride is a highly specific and selective tryptase inhibitor, exhibiting a Ki of 620 pM for recombinant human tryptase-β (rHTβ)[1][2].

CRA-2059 is a highly specific and selective tryptase inhibitor with a Ki of 620 pM for recombinant human tryptase-β (rHTβ) [1][2].

CRA-2059 is a selective and reversible inhibitor of human tryptase beta, exhibiting a Ki value of 620 pM against recombinant human tryptase beta (rHTβ).

DORA-22 is a dual orexin receptor antagonist, improves mild stress-induced insomnia with minimal effect on memory

3-Acetoxy-24-hydroxydammara-20,25-diene is a natural product for research related to life sciences. The catalog number is TN2914 and the CAS number is 143519-04-4.

Mopidamol (RA 233) is a phosphodiesterase inhibitor, a dipyridamole derivative, with anticancer activity that prevents retinal vascular defects in experimental diabetes.

Tetrahexyldecyl ascorbate (BV-OSC) is a lipophilic precursor of ascorbic acid, a more stable and permeable form of vitamin C. It is a potent anti-photo-aging and anti-hyperpigmentation antioxidant that inhibits MMP enzyme activity.

PCI-24781 (Abexinostat (PCI24781)) is a new pan-HDAC inhibitor mainly targeting HDAC1 (Ki: 7 nM), also have moderate inhibitory for HDACs 2, 3, 6, and 10 and greater than 40-fold selectivity against HDAC8. Phase 1/2.

AR-A 2 is a selective 5-HT1B receptor antagonist with high affinity to guinea pig cortex 5-HT1B/1D and recombinant guinea pig 5-HT1B receptors (Ki: 0.24 and 0.47 nM), exhibiting a 10-fold lower affinity to guinea pig 5-HT1D receptor (Ki: 5 nM).

AB928 is an orally bioavailable, selective dual adenosine receptor (A2aR/A2bR) antagonist. It has immunomodulatory activity[1].

meso-Tetra-(2-thienyl)porphine is a synthetic porphyrin compound capable of binding to DNA through secondary interactions along the external (minor) grooves of the DNA macromolecule. Additionally, meso-Tetra-(2-thienyl)porphine exhibits electrochemical redox properties.

ADORA2A/PDE4D-IN-1 (Compound 9) is a dual inhibitor of the adenosine A2a receptor (ADORA2A) and phosphodiesterase 4D (PDE4D). This compound is applicable for research in bronchial asthma.

A2AR/A2BR antagonist 1 (compound 7ai) acts as a dual antagonist to A2AR and A2BR with IC50 values of 11.2 nM and 6.4 nM, respectively. Additionally, A2AR/A2BR antagonist 1 enhances T cell-mediated cancer cell death.

ADRA2A antagonist 1 (compd 4n) is a potent and selective ADRA2A antagonist with an IC50 of 18 nM. It is applicable in the research of inflammation and sepsis.

UCF 101 is a specific inhibitor of HtrA2 and reduces apoptosis in PC12 cells.

RA 263 is a nucleoside.

Anti-IL-13Ra2/CD213a2 is a human-derived antibody produced in CHO cells, specifically targeting IL-13Ra2/CD213a2. The predicted molecular weight (MW) of Anti-IL-13Ra2/CD213a2 is 150 kDa. For isotype control, refer to HumanIgG1kappa, Isotype Control.

Cibinetide (ARA290) is a nonerythropoietic peptide engineered from erythropoietin,, and used for neurological disease treatment.